{"transactions":[{"id":1077857,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-08-01T18:03:29.000Z","date":"2025-07-30","kind":"purchase","planned":false,"acquired":true,"shares":133333,"price":1.5,"value":199999.5,"ownership":{"direct":true},"balance_after":11570833,"source":{"system":"sec-edgar","filing":"0001437749-25-024427","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774925024427/rdgdoc.xml","form_type":"4"}},{"id":1402769,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-19T20:21:45.000Z","date":"2024-09-18","kind":"purchase","planned":false,"acquired":true,"shares":125000,"price":0.75,"value":93750.0,"ownership":{"direct":true},"balance_after":11437500,"source":{"system":"sec-edgar","filing":"0001437749-24-029634","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774924029634/rdgdoc.xml","form_type":"4"}},{"id":1507668,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-21T15:14:11.000Z","date":"2024-05-20","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.75,"value":75000.0,"ownership":{"direct":true},"balance_after":11312500,"source":{"system":"sec-edgar","filing":"0001437749-24-017815","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774924017815/rdgdoc.xml","form_type":"4"}},{"id":1703680,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-20T14:05:32.000Z","date":"2023-12-19","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":0.5,"value":75000.0,"ownership":{"direct":true},"balance_after":11212500,"source":{"system":"sec-edgar","filing":"0001437749-23-034984","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774923034984/rdgdoc.xml","form_type":"4"}},{"id":1815267,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-04T13:41:20.000Z","date":"2023-08-01","kind":"purchase","planned":false,"acquired":true,"shares":62500,"price":2,"value":125000.0,"ownership":{"direct":true},"balance_after":11062500,"source":{"system":"sec-edgar","filing":"0001437749-23-022109","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774923022109/rdgdoc.xml","form_type":"4"}},{"id":2286924,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-05-02T12:21:08.000Z","date":"2022-04-29","kind":"purchase","acquired":true,"shares":804868,"price":1,"value":804868.0,"ownership":{"direct":true},"balance_after":11000000,"source":{"system":"sec-edgar","filing":"0001437749-22-010378","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922010378/rdgdoc.xml","form_type":"4"}},{"id":2290540,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-26T21:28:34.000Z","date":"2021-12-30","kind":"other","acquired":false,"shares":1431615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions relate to an amendment of the exercise price of outstanding warrants contingent upon the Reporting Person exercising the warrants. As a result, the outstanding warrants were deemed cancelled and modified warrants were issued for the same number of shares of Common Stock, but with a reduced exercise price."}],"balance_after":0,"derivative":{"exercise_price":0.2,"exercise_date":"2021-12-01","expiration_date":"2022-01-31","underlying":"Common Stock","underlying_shares":1431615},"source":{"system":"sec-edgar","filing":"0001437749-22-009785","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922009785/rdgdoc.xml","form_type":"5"}},{"id":2290539,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-26T21:28:34.000Z","date":"2021-12-01","kind":"other","acquired":false,"shares":1431615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Cancelled in accordance with Warrant Modification Agreement  dated as of 12/01/21"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions relate to an amendment of the exercise price of outstanding warrants contingent upon the Reporting Person exercising the warrants. As a result, the outstanding warrants were deemed cancelled and modified warrants were issued for the same number of shares of Common Stock, but with a reduced exercise price."}],"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2020-10-05","expiration_date":"2025-10-05","underlying":"Common Stock","underlying_shares":1431615},"source":{"system":"sec-edgar","filing":"0001437749-22-009785","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922009785/rdgdoc.xml","form_type":"5"}},{"id":2290538,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-26T21:28:34.000Z","date":"2021-12-01","kind":"other","acquired":true,"shares":1431615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquired in accordance with Warrant Modification Agreement  dated as of 12/01/21"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transactions relate to an amendment of the exercise price of outstanding warrants contingent upon the Reporting Person exercising the warrants. As a result, the outstanding warrants were deemed cancelled and modified warrants were issued for the same number of shares of Common Stock, but with a reduced exercise price."}],"balance_after":1431615,"derivative":{"exercise_price":0.2,"exercise_date":"2021-12-01","expiration_date":"2022-01-31","underlying":"Common Stock","underlying_shares":1431615},"source":{"system":"sec-edgar","filing":"0001437749-22-009785","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922009785/rdgdoc.xml","form_type":"5"}},{"id":2290537,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-04-26T21:28:34.000Z","date":"2021-12-30","kind":"other","acquired":true,"shares":1431615,"price":0.2,"value":286323.0,"ownership":{"direct":true},"balance_after":10195132,"source":{"system":"sec-edgar","filing":"0001437749-22-009785","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922009785/rdgdoc.xml","form_type":"5"}},{"id":2290536,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-26T21:24:57.000Z","date":"2020-10-05","kind":"other","acquired":false,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Cancelled in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transactions involved a recapitalization resulting in the deemed cancellation of the \"old\" warrants and the deemed grant of \"replacement\" warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Originally exercisable on 11/15/19 and 12/06/19, with expirations of 11/15/24 and 12/06/24, respectively, for 15,000 shares and 150,000 shares"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Originally exercisable on 11/15/19 and 12/06/19, with expirations of 11/15/24 and 12/06/24, respectively, for 15,000 shares and 150,000 shares"}],"balance_after":0,"derivative":{"exercise_price":0.4,"underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001437749-22-009782","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922009782/rdgdoc.xml","form_type":"5"}},{"id":2290535,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-26T21:24:57.000Z","date":"2020-10-05","kind":"other","acquired":true,"shares":1431615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported transactions involved a recapitalization resulting in the deemed cancellation of the \"old\" warrants and the deemed grant of \"replacement\" warrants."}],"balance_after":1431615,"derivative":{"exercise_price":0.4,"exercise_date":"2020-10-05","expiration_date":"2025-10-05","underlying":"Common Stock","underlying_shares":1431615},"source":{"system":"sec-edgar","filing":"0001437749-22-009782","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922009782/rdgdoc.xml","form_type":"5"}},{"id":2290534,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-04-26T21:24:57.000Z","date":"2020-10-05","kind":"purchase","acquired":true,"shares":175000,"price":0.4,"value":70000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Purchase shares acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020"}],"balance_after":8763517,"source":{"system":"sec-edgar","filing":"0001437749-22-009782","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922009782/rdgdoc.xml","form_type":"5"}},{"id":2290533,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-04-26T21:24:57.000Z","date":"2020-10-05","kind":"other","acquired":true,"shares":302205,"price":0.4,"value":120882.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Conversion shares acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020"}],"balance_after":8588517,"source":{"system":"sec-edgar","filing":"0001437749-22-009782","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922009782/rdgdoc.xml","form_type":"5"}},{"id":2290532,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-26T21:21:36.000Z","date":"2019-12-06","kind":"purchase","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired in connection with Note Purchase Agreement dated as of November 15, 2019"}],"balance_after":165000,"derivative":{"exercise_price":0.4,"exercise_date":"2019-12-06","expiration_date":"2024-12-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-22-009779","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922009779/rdgdoc.xml","form_type":"5"}},{"id":2290531,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Warrants to purchase Common Stock","published_at":"2022-04-26T21:21:36.000Z","date":"2019-11-15","kind":"purchase","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired in connection with Note Purchase Agreement dated as of November 15, 2019"}],"balance_after":15000,"derivative":{"exercise_price":0.4,"exercise_date":"2019-11-15","expiration_date":"2024-11-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-22-009779","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922009779/rdgdoc.xml","form_type":"5"}},{"id":4235603,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-08-14T15:25:34.000Z","date":"2017-08-10","kind":"purchase","acquired":true,"shares":5220000,"price":0.2222,"value":1159884.0,"ownership":{"direct":true},"balance_after":8286312,"source":{"system":"sec-edgar","filing":"0000899243-17-020218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000089924317020218/doc4.xml","form_type":"4"}}]}